Shots:
- QIAGEN to integrate its Digital Insights bioinformatics business with NVIDIA accelerated computing & the NVIDIA BioNeMo platform to strengthen AI applications in drug discovery
- Partnership leverages graph-based AI that apply retrieval & reasoning techniques across biomedical knowledge graphs to help researchers analyze complex biological data & validate AI-generated insights, supporting practical applications across the drug discovery lifecycle
- The AI-enhanced solutions will integrate frameworks such as PyTorch Geometric & GPU-accelerated GraphRAG systems via NVIDIA BioNeMo, with pilot programs initially targeting select pharma & biotech partners ahead of broader rollout following validation
Ref: Businesswire | Image: QIAGEN & NVIDIA | Press Release
Related News: QIAGEN Launches QIAstat-Dx BCID GPF Plus AMR Panel for Bloodstream Infection Syndromic Testing
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
